BioengineeringbioRxiv
Homogeneity of antibody-drug conjugates critically impacts the therapeutic efficacy in brain tumors
Y. Anami, Y. Otani, W. Xiong…·K. Tsuchikama
This study shows that homogeneous antibody-drug conjugates (ADCs) improve therapeutic efficacy in glioblastoma models compared to heterogeneous ADCs.
DOI 10.1016/j.celrep.2022.110839